Skin Reactions as a Prognostic Factor in Immunotherapy of Non-Small Cell Lung Cancer.
- Published in:
- International Medical Journal, 2025, v. 32, n. 2, p. 97
- By:
- Publication type:
- Article
Works by Szklener, Katarzyna
Results: 27
1
2
Enfortumab Vedotin - A New Hope in the Treatment of Advanced Bladder Cancer.
- Published in:
- International Medical Journal, 2025, v. 32, n. 2, p. 72
- By:
- Publication type:
- Article
3
Trichomegaly as a rare complication of panitumumab therapy for colon cancer.
- Published in:
- Oncology in Clinical Practice (2450-1654), 2024, v. 20, n. 5, p. 380, doi. 10.5603/ocp.98272
- By:
- Publication type:
- Article
4
Hypopituitarism as a rare complication of lung cancer immunotherapy.
- Published in:
- Oncology in Clinical Practice (2450-1654), 2023, v. 19, n. 3, p. 203, doi. 10.5603/OCP.2023.0013
- By:
- Publication type:
- Article
5
Management of hepatocellular carcinoma with novel immunotherapeutic agents and prospects for the future.
- Published in:
- Nowotwory, 2021, v. 71, n. 6, p. 391, doi. 10.5603/NJO.2021.0073
- By:
- Publication type:
- Article
6
Long-Term Survival of a Patient with Metastatic Bladder Cancer Treated with Avelumab.
- Published in:
- International Medical Journal, 2025, v. 32, n. 1, p. 42
- By:
- Publication type:
- Article
7
Unusual Complications during Immunotherapy in a Patient with Clear Cell Renal Cell Carcinoma.
- Published in:
- International Medical Journal, 2024, v. 31, n. 6, p. 188
- By:
- Publication type:
- Article
8
Lung Adenocarcinoma with Unusual Genetic Mutations: Case Report.
- Published in:
- International Medical Journal, 2024, v. 31, n. 1, p. 22
- By:
- Publication type:
- Article
9
Ibrutinib in the Treatment of Solid Tumors: Current State of Knowledge and Future Directions.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 8, p. 1338, doi. 10.3390/cells11081338
- By:
- Publication type:
- Article
10
Immunological insights: assessing immune parameters in medical professionals exposed to SARS-CoV-2.
- Published in:
- BMC Infectious Diseases, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12879-024-09772-5
- By:
- Publication type:
- Article
11
Immunological insights: assessing immune parameters in medical professionals exposed to SARS-CoV-2.
- Published in:
- BMC Infectious Diseases, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12879-024-09772-5
- By:
- Publication type:
- Article
12
Association between smoking status, toxicity and survival in the checkpoint inhibitor immunotherapy.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1459608
- By:
- Publication type:
- Article
13
The effectiveness of acupuncture in cancer pain treatment.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1450105
- By:
- Publication type:
- Article
14
EXCEPTIONALLY LONG SURVIVAL WITH LORLATINIB IN A PATIENT WITH ALK-REARRANGED LUNG CANCER.
- Published in:
- Pharmacophore, 2023, v. 14, n. 4, p. 1, doi. 10.51847/n1YjZeJNBd
- By:
- Publication type:
- Article
15
Ozone in Chemotherapy-Induced Peripheral Neuropathy—Current State of Art, Possibilities, and Perspectives.
- Published in:
- 2023
- By:
- Publication type:
- Literature Review
16
Stereotactic radiosurgery in the treatment of essential tremor -- a systematic review.
- Published in:
- Frontiers in Neurology, 2024, p. 01, doi. 10.3389/fneur.2024.1370091
- By:
- Publication type:
- Article
17
Metformin in the treatment of colorectal cancer and neuroendocrine tumours.
- Published in:
- Contemporary Oncology / Współczesna Onkologia, 2024, v. 28, n. 2, p. 85, doi. 10.5114/wo.2024.142553
- By:
- Publication type:
- Article
18
Successful chemotherapy of a recurrent anaplastic oligodendroglioma with irinotecam.
- Published in:
- European Journal of Clinical & Experimental Medicine, 2025, v. 23, p. 131
- By:
- Publication type:
- Article
19
Moderate toxicity with late onset as a good omen: association between toxicity and survival in the checkpoint inhibitor immunotherapy—a single center experience.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1527103
- By:
- Publication type:
- Article
20
Phytochemicals in Cancer Treatment and Cancer Prevention—Review on Epidemiological Data and Clinical Trials.
- Published in:
- Nutrients, 2023, v. 15, n. 8, p. 1896, doi. 10.3390/nu15081896
- By:
- Publication type:
- Article
21
Dietary Supplements in Chemotherapy-Induced Peripheral Neuropathy: A New Hope?
- Published in:
- Nutrients, 2022, v. 14, n. 3, p. 625, doi. 10.3390/nu14030625
- By:
- Publication type:
- Article
22
New Directions in the Therapy of Glioblastoma.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5377, doi. 10.3390/cancers14215377
- By:
- Publication type:
- Article
23
New Directions and Challenges in Targeted Therapies of Advanced Bladder Cancer: The Role of FGFR Inhibitors.
- Published in:
- Cancers, 2022, v. 14, n. 6, p. 1416, doi. 10.3390/cancers14061416
- By:
- Publication type:
- Article
24
Breast cancer associated with pregnancy -- a review of therapeutic approaches.
- Published in:
- Journal of Pre-Clinical & Clinical Research, 2024, v. 18, n. 2, p. 156, doi. 10.26444/jpccr/189445
- By:
- Publication type:
- Article
25
Glioblastoma mimicking Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS) syndrome - case Report.
- Published in:
- Journal of Pre-Clinical & Clinical Research, 2022, v. 16, n. 3, p. 85, doi. 10.26444/jpccr/154733
- By:
- Publication type:
- Article
26
Obesity and lung cancer - is programmed death ligand-1 (PD-1L) expression a connection?
- Published in:
- Archives of Medical Science, 2024, v. 20, n. 1, p. 313, doi. 10.5114/aoms/175470
- By:
- Publication type:
- Article
27
Enhancing glioblastoma treatment through the integration of tumor-treating fields.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1274587
- By:
- Publication type:
- Article